BiomX Inc. (PHGE) Balance Sheet

NYSE American: PHGEAssets, liabilities, debt and equity over 9 years.

PHGE balance sheet, 2025

December 31, 2025 · U.S. dollars

$70.2M assets = $71.5M liabilities + −$1.3M equity

What it owns$70.2MCash & ST investments: $5.0M (7.1%)$5.0MOther current: $620,000 (0.9%)PP&E: $157,000 (0.2%)Goodwill & intangibles: $208,000 (0.3%)Other non-current: $64.3M (91.5%)Other non-current$64.3M · 92%=How it is financed$71.5MCurrent liabilities: $6.4M (8.9%)Current liabilities $6.4MOther LT liabilities: $65.2M (91.1%)Other LT liabilities$65.2M · 91%

Liabilities exceed assets: shareholders’ equity is negative (−$1.3M).

Both columns are drawn to the same scale: what PHGE owns equals what it owes plus shareholders’ equity. Hover a block for its value.

PHGE financial health

Current ratio0.87
Tight · current assets cover current liabilities 0.87×
Equity / assets−1.9%
Thin equity · of assets funded by shareholders
Cash / debt345.1%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.3%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

PHGE balance sheet trends, 2017–2025

BiomX Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$14.0M2017$70.2M2025+22.3%/yr
Total liabilities$2.5M2017$71.5M2025+52.4%/yr
Shareholders’ equity$11.5M2017−$1.3M2025—
Cash & short-term investments$8.1M2017$5.0M2025−6.0%/yr
Total debt$40,0002017$1.4M2025+56.5%/yr
Net cash (debt)$8.1M2017$3.5M2025−$4.6M
Working capital$7.0M2017−$804,0002025−$7.8M
Current ratio5.8120170.872025−4.93
Debt / equity0.0020170.402024+0.39

Change is the average annual growth (CAGR) or the difference between the first and latest year.

PHGE assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

PHGE liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

PHGE debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

PHGE balance sheet

BiomX Inc. annual balance sheet
202520242023202220212020201920182017
Assets
Cash & short-term investments$5.0M$17.8M$14.9M$33.3M$62.1M$56.3M$82.4M$39.7M$8.1M
Cash & equivalents$5.0M$17.8M$14.9M$31.3M$62.1M$36.5M$72.4M$8.6M$7.0M
Short-term investments——$0$2.0M$0$19.9M$10.0M$31.1M$1.2M
Receivables$0$1.2M$574,000$567,000$888,000$276,000$244,000$129,000$327,000
Inventory$0−$958,000$0$395,000$108,000$0$2.0M−$29,000$0
Other current assets$620,000$2.5M$2.2M$2.6M$3.5M$4.1M$0$129,000$0
Total current assets$5.6M$20.5M$17.6M$36.9M$66.6M$60.7M$84.5M$39.9M$8.5M
Property, plant & equipment (net)$157,000$10.5M$7.4M$8.7M$9.8M$6.7M$3.0M$887,000$960,000
Goodwill & intangible assets$208,000$12.1M$0$0$1.5M$3.0M$4.6M$4.6M$0
Long-term investments$0$0$0$0$0$0$0$70.9M$0
Other non-current assets$64.3M$161,000$0$0$0$0$5,000$0$4.6M
Total assets$70.2M$43.2M$25.0M$45.5M$78.0M$70.4M$92.1M$45.3M$14.0M
Liabilities
Accounts payable$3.1M$1.9M$1.4M$820,000$2.8M$2.3M$3.3M$56,581$1,000
Short-term debt$1.4M$1.1M$6.5M$5.0M$819,000$863,000$375,000—$40,000
Deferred revenue——$28,000$242,000$2.0M$65,000$60,000$58,000−$40,000
Total current liabilities$6.4M$8.3M$11.2M$7.9M$11.0M$7.2M$6.2M$1.6M$1.5M
Long-term debt$0$0$5.4M$10.6M$14.4M$5.0M$0$500,000$0
Lease obligations$1.4M$9.6M$3.9M$4.5M$5.6M$5.9M$1.2M$0—
Other long-term liabilities$65.2M$10.8M$5.4M$6.0M$5.0M$701,000$1.4M$389,000$1.0M
Total liabilities$71.5M$19.1M$21.9M$24.5M$30.5M$12.9M$7.7M$2.5M$2.5M
Shareholders' equity
Common stock & paid-in capital$7,000$6,000$3,000$2,000$2,000$2,000$2,000$65.7M$201
Retained earnings (deficit)−$216.9M−$180.7M−$163.0M−$136.8M−$108.5M−$72.3M−$42.2M−$21.6M−$8.9M
Accumulated other comprehensive income————$0−$72.3M−$42.2M−$21.6M−$1,025
Total shareholders' equity−$1.3M$24.1M$3.1M$21.0M$47.5M$57.5M$84.5M$42.8M$11.5M
Key figures
Total debt$1.4M$9.6M$15.1M$19.4M$20.0M$5.9M$1.2M$500,000$40,000
Net cash (debt)$3.5M$8.2M−$185,000$14.0M$42.1M$50.4M$81.2M$39.2M$8.1M
Working capital−$804,000$12.3M$6.5M$28.9M$55.6M$53.5M$78.3M$38.2M$7.0M
Tangible book value−$1.5M$12.1M$3.1M$21.0M$46.0M$54.4M$79.9M$38.2M$11.5M
Current ratio0.872.481.584.656.038.4713.5824.345.81
Quick ratio0.782.301.394.275.707.9013.2824.285.81
Debt / equity—0.404.900.920.420.100.010.010.00
Equity / assets−1.9%55.9%12.3%46.2%61.0%81.7%91.7%94.4%82.4%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed February 19, 2026); data from EODHD.

PHGE financial position

At the end of fiscal 2025 (December 31, 2025), BiomX had total assets of $70.2 million (up 62.5% from a year earlier), total liabilities of $71.5 million and shareholders' equity of -$1.3 million. It held $5.0 million in cash and short-term investments against $1.4 million of debt, a net cash position of $3.5 million. Its current ratio was 0.87. In the latest quarter (ended June 30, 2026) total assets were $28.2 million and equity $10.9 million.

Related: PHGE income statement, PHGE cash flow statement, PHGE key metrics. See the PHGE stock overview for the latest quote and news.

PHGE balance sheet FAQ

What are BiomX's total assets?

BiomX reported total assets of $70.2 million at the end of fiscal 2025 (December 31, 2025), compared with $43.2 million a year earlier.

How much debt does BiomX have?

BiomX had $1.4 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was —.

How much cash does BiomX have?

BiomX held $5.0 million in cash and short-term investments at the end of fiscal 2025; with $1.4 million of debt that is net cash of $3.5 million.

What is BiomX's book value?

BiomX's shareholders' equity (book value) was -$1.3 million at the end of fiscal 2025.

What is BiomX's current ratio?

BiomX had current assets of $5.6 million and current liabilities of $6.4 million, a current ratio of 0.87 (current liabilities exceed current assets).

How much goodwill does BiomX have?

BiomX carried $0.2 million of goodwill and intangible assets, 0.3% of total assets, at the end of fiscal 2025.